Together, these results demonstrated that adipose-specific Blnc1 inactivation or transgenic expression exacerbated or alleviated diet-induced systemic IR and hepatic steatosis by promoting or suppressing BAT whitening and eWAT inflammation, respectively. This evidence concerns the gene PAQR9 and fatty liver disease.